Amethyst Healthcare Announces Júlio Teixeira to Join Amethyst Network
Lisbon / Porto / Braga – 6th October, 2025
Amethyst Healthcare today announces the acquisition of Júlio Teixeira, a well-established provider of radiotherapy services operating in Porto and Braga. This acquisition forms part of Amethyst’s strategic expansion in Western Europe and will strengthen the Group’s capacity to deliver advanced radiotherapy care in Portugal.
Júlio Teixeira will continue to provide uninterrupted patient care while its clinical and operational teams are integrated into Amethyst’s governance and quality frameworks. The acquisition gives access to pan-European clinical best practice, structured professional development, and targeted capital investment to support ongoing service expansion. Amethyst was supported on the transaction by Finantia, (Narciso Melo), CMS Portugal, (Francisco Xavier de Almeida), PwC Financial Due Diligence (Luís Boquinhas) and LEK Commercial Due diligence (Jacqueline Thompson).
“Today we formalise an important step in our commitment to improve access to high-quality radiotherapy,” said Stéphane Carré, Chief Executive Officer, Amethyst Healthcare. “Our priority is maintaining continuity of care for patients, supporting staff through the transition, and investing in the services and infrastructure to build on clinical excellence across these centres.”
Amethyst Healthcare will work closely with local teams and regulatory authorities to ensure a smooth transition and to preserve the clinical excellence Júlio Teixeira has delivered to its patients for decades.
<< ENDS >>
About Amethyst Healthcare
Founded in 2010, Amethyst Healthcare is the largest private provider of Radiotherapy services in Europe treating over 50,000 patients a year. It operates some of the highest volume Linear Accelerators (Linacs) in Europe, with 220 patients a day treated in its high-volume centers; equivalent to +70 patients per Linac per day; bringing treatment times to eight minutes per treatment fraction. This is double the typical Linac utilization.
Amethyst delivers next generation (non-surgical) oncology treatment across the international Cancer Care market in Austria, France, Italy, Poland, Romania and the UK, operating 17 specialist centres, comprising 34 Linear Accelerators (Linacs) and two Gamma Knife Radiosurgery centers.
About Júlio Teixera
Júlio Teixeira S.A. is a leading private provider of radiotherapy in Portugal with treatment centers in Porto and Brag. Founded in 1994 by Dr Júlio Teixeira, one of Portugal most respected radiation oncologists. Its multidisciplinary team of radiation oncologists, physicists and specialized nurses deliver a full range of advanced therapies, including IMRT, Cyberknife and brachytherapy.
For media inquiries, please contact: Sophie Ward, Amethyst Healthcare [email protected]
